Illustration of herpes virus interacting with skin and immune cells, representing different immune responses.

Herpes vs. Your Cells: Why Your Immune Response Differs

Author's portrait.
Jordan Keane in Health & Wellness December 2025 • 4 min read.

"Uncover how HSV-2 manipulates your skin and immune cells, impacting inflammation and potential treatments."


Herpes simplex virus type 2 (HSV-2) is a common virus, affecting a significant portion of the adult population worldwide. While known for causing genital herpes, the way it interacts with our body's cells is complex and not fully understood. One crucial aspect is how HSV-2 influences inflammation, the body's natural response to infection.

The Fas/FasL pathway is a key player in the immune system. Think of it as a cellular 'death switch.' When activated, it can trigger infected cells to self-destruct, preventing the virus from spreading. However, viruses like HSV-2 can manipulate this pathway to their advantage.

New research sheds light on how HSV-2 interacts with the Fas/FasL pathway in different types of cells: keratinocytes (the main cells in your skin) and monocytes (a type of immune cell). This article breaks down these findings, explaining why the inflammatory response to HSV-2 differs depending on the cell type and what this means for future treatments.

HSV-2: A Tale of Two Cell Types

Illustration of herpes virus interacting with skin and immune cells, representing different immune responses.

The study examined how HSV-2 impacts keratinocytes and monocytes, focusing on inflammation. Researchers infected these cells with HSV-2 and then stimulated the Fas receptor (the 'death switch') using a specific antibody. They then measured the levels of key inflammatory signals (cytokines and chemokines) produced by the cells.

Here's a breakdown of what they discovered:

  • Keratinocytes: When infected with HSV-2, these skin cells become resistant to Fas-induced apoptosis (self-destruction). Surprisingly, stimulating the Fas receptor in these infected keratinocytes actually reduced the production of inflammatory signals.
  • Monocytes: Unlike keratinocytes, HSV-2-infected monocytes were susceptible to Fas-induced apoptosis. Moreover, stimulating the Fas receptor did not reduce inflammation in these cells; instead, inflammation remained high or even increased.
These results indicate that HSV-2 manipulates the Fas/FasL pathway differently in keratinocytes and monocytes. In keratinocytes, it seems to suppress both apoptosis and inflammation, potentially allowing the virus to persist longer in the skin. In monocytes, it triggers cell death without reducing inflammation, possibly contributing to the overall immune response.

The Bigger Picture: Implications for Treatment

This research highlights the complex interplay between HSV-2 and the immune system. By understanding how the virus manipulates different cell types, scientists can potentially develop more targeted antiviral therapies.

For example, future treatments might focus on:

<ul> <li><b>Keratinocytes:</b> Developing drugs that can overcome the HSV-2-induced resistance to apoptosis in keratinocytes, allowing for the elimination of infected skin cells.</li> <li><b>Monocytes:</b> Modulating the inflammatory response of monocytes to prevent excessive inflammation and tissue damage.</li> </ul>

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What is HSV-2 and what is it associated with?

HSV-2 is a virus that causes genital herpes. It's a common virus affecting many adults globally. The way it interacts with the body's cells, particularly how it influences inflammation, is complex. The research focuses on this interaction to understand the disease better and potentially find new treatments.

2

What is the Fas/FasL pathway and why is it important?

The Fas/FasL pathway is a critical part of the immune system, acting as a cellular 'death switch.' When activated, this pathway causes infected cells to self-destruct, preventing the virus from spreading. HSV-2 can manipulate this pathway, which affects how the body responds to the virus, leading to differences in inflammation and cell death depending on the cell type.

3

What did the study examine regarding HSV-2?

The study examined how HSV-2 affects keratinocytes (skin cells) and monocytes (immune cells). In keratinocytes, HSV-2 made the cells resistant to the Fas pathway, reducing inflammation. In monocytes, HSV-2 did not reduce inflammation and triggered the cell death through the Fas pathway. This suggests HSV-2 manipulates the Fas/FasL pathway differently in different cell types.

4

How did HSV-2 affect the inflammatory response in the different cells?

The study found that in keratinocytes, stimulating the Fas receptor actually *reduced* inflammation when infected with HSV-2. Conversely, in monocytes, stimulating the Fas receptor did not reduce inflammation. This difference shows that HSV-2 manipulates the Fas/FasL pathway differently depending on the cell type, impacting the inflammatory response.

5

What are the implications of these findings for treatment?

Understanding how HSV-2 manipulates the Fas/FasL pathway in different cells, like keratinocytes and monocytes, allows for the development of more targeted antiviral therapies. This could mean treatments that specifically address the virus's ability to evade the immune system in the skin and promote cell death in immune cells, leading to better control of the infection and reduced symptoms.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.